Gilead Sciences Stock Price (NASDAQ:GILD)

Add to My Stocks
$68.55 $0.03 (0.04%) GILD stock closing price Apr 28, 2017 (Closing)
Gilead Sciences
28 APR 2017
amigobulls logo
GILD hand_up
GILD vs S&P 500
Closing Price: Apr 28, 2017
$68.55 ( -0.04%)
S&P 500
2384.2 ( -0.19%)
52 Week Price Range
1 Year Return: -29.3%
Q4 Growth*
Profitable ?
net image
2016 Q4 Net Profit
Pays Dividend ?
12 Months Dividend
  : $1.84
Dividend Yield
  : 2.77%
PE Valuation
home image
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen

Gilead Sciences Snapshot Video

137 5 2

GILD Stock Details

Prev Close* : $68.58
Market Cap:
Day Low: $68.24
52 Week Low: $65.38
Open: $68.83
Volume: 6257542
Day High: $68.96
52 Week High: $101.78

Gilead Sciences, Inc. Business Profile

Gilead Sciences, Inc., is an American multinational corporation, headquartered in Foster City, California. Gilead Sciences, Inc. was founded in 1987, by Michael L. Riordan, a 29 year old medical doctor. The company is listed on Nasdaq and trades with the ticker symbol GILD. Gilead Sciences, Inc. is a research-based bio-pharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. he company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Gilead stock has yielded phenomenal returns to its investors in the last five years as can be seen from href="" class="linkblue" title="Gilead historical stock prices">. The Gilead valuation shows the fundamental analysis of Gilead. It analyzes the revenue and profit growth over the past quarters to determine the financial health of the company. Gilead is a company which is continuously innovating. The company is mainly focused on developing the cure for Hepatitis C and HIV. The company shot into limelight after it developed the wonder drugs Haravoni and Sovaldi for treating Hepatitis C patients.

If one checks , one will see that Gilead stock price more than doubled after the launch of Harovini and Sovaldi.

More Information:


Gilead Investor Relations

Gilead Financial Information

more on GILD business profile

Gilead Sciences Stock Articles & Video

more news on GILD stock

Gilead Sciences News - From Partners

Did Pharma & Biotech M&As Pick Pace in Q1?   by Zacks on Apr 18, 2017
Bear of the Day: Gilead Sciences (GILD)   by Zacks on Apr 06, 2017

GILD Stockcharts

View GILD PE ratio, PS ratio stocks charts and compare with peers.
GILD Chart
Note: Compare Gilead Sciences stock price history with the index and industry peers.

Gilead Sciences Valuation

PE ratio
(price earnings ratio)
PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Gilead Sciences Returns

(return on equity)

Gilead Sciences Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield

GILD Industry Peers

Company Price Change (%)
Amgen (AMGN)163.320.6 (0.37%)
Celgene (CELG)124.050.08 (0.06%)
Pfizer (PFE)33.920.06 (0.18%)
Roche Holdings (RHHBY)32.70.04 (0.12%)
Glaxosmithkline (GSK)40.90.12 (0.29%)
Johnson & Johnson (JNJ)123.470.27 (0.22%)
Bristol-myers Squibb (BMY)56.050.38 (0.68%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
MiMedx (MDXG)12.691.29 (11.32%)
Regeneron Pharma (REGN)388.4921.87 (5.97%)
Evogene (EVGN)5.360.3 (5.93%)
Sarepta Therapeutics (SRPT)36.261.54 (4.44%)
Acorda Therapeutics (ACOR)16.150.6 (3.86%)
Alkermes (ALKS)58.251.95 (3.46%)
Heska (HSKA)108.253.03 (2.88%)
Top gainers from Medical-Biomed-Genetics industry
* As of Apr 28, 2017
CompanyPriceChange (%)
Sorrento Therapeutics (SRNE)1.950.15 (7.14%)
Revance (RVNC)21.751.55 (6.65%)
ZIOPHARM Oncology (ZIOP)7.040.47 (6.26%)
Alder BioPharma (ALDR)20.051.3 (6.09%)
Mirati Therapeutics (MRTX)4.550.23 (4.82%)
Idera Pharma (IDRA)2.350.1 (4.08%)
Curis (CRIS)2.420.1 (3.97%)
Top losers from Medical-Biomed-Genetics industry
* As of Apr 28, 2017

Gilead Sciences, Inc. Stock News - Partner Headlines

Gilead Sciences Financial Statements

income statement20162015201420132012
Net Sales Or Revenues30.39B32.64B24.89B11.2B9.7B
Net Income13.5B18.11B12.1B3.07B2.59B
Total Operating Expense8.5B6.44B5.84B3.82B3.22B
view Gilead Sciences, Inc. income statement
balance sheet20162015201420132012
Total Assets56.98B51.84B34.66B22.5B21.24B
Total Liabilities37.61B32.73B18.85B10.75B11.69B
Shareholders Equity19.36B19.11B15.82B11.74B9.55B
view Gilead Sciences, Inc. balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities1.36B1.16B-518M-562.67M177.06M
Net Cash From (Used By) Operating Activities16.67B20.33B12.82B3.1B3.19B
Increase (Decrease) In Prop Plant And Equipment-748M-747M-557M-190.78M-397.04M
view Gilead Sciences, Inc. cashflow statement

Gilead Sciences Stock Message Board

Gilead Sciences stock lost 0.53 %, and the last close price as of 27 Apr, 2017 is 68.58 for GILD stock. Gilead Sciences market capitalization is 89.18B and it represents the total market value of GILD stock. A value investor must look at the fundamentals of a stock, and perform Gilead Sciences valuation, even though in the short-term sentiment and current breaking news might affect Gilead Sciences stock price.

The terms stocks and shares mean the same thing. For Ex: Gilead Sciences stock price and Gilead Sciences share price mean the same thing. 6734653 GILD shares were traded yesterday, and Gilead Sciences stock chart shows that the GILD stock quote hit a day high of 68.76 and day low of 68.05. The board of directors decide what percentage of a company's earnings will be paid out as dividends. Gilead Sciences stock dividend was 2.08 during the last quarter. To check the historical stock price movement, all time high, and all time low of GILD, view Gilead Sciences stock price history.